论文期刊

取消

高级检索

检索历史清除

首页> Clinics (Sao Paulo, Brazil)> Comparative efficacy & safety of buparlisib plus fulvestrant, fulvestrant plus dalpiciclib, and ribociclib plus letrozole for postmenopausal, hormone receptor-positive, and HER2-negative breast cancer.

Comparative efficacy & safety of buparlisib plus fulvestrant, fulvestrant plus dalpiciclib, and ribociclib plus letrozole for postmenopausal, hormone receptor-positive, and HER2-negative breast cancer.

导出 OA

翻译打印收藏纠错

作者： Qi,Liu ^[1] ; Lingli,Hou ^[2] ; Ying,Zhao ^[3] ; Hongwei,Yang ^[3] ; Zhengying,Mo ^[4] ; Fei,Yu ^[5]

作者单位： Department of Human Anatomy, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, PR China. ^[1] Department of Clinical Laboratory, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, PR China. Electronic address: 845430552@qq.com. ^[2] Department of Clinical Laboratory, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, PR China. ^[3] Department of Oncology, Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, PR China. ^[4] Department of Clinical Laboratory, People's Hospital of Yunxi County, Yunxi, PR China. ^[5]

关键词 Breast cancer Buparlisib Dalpiciclib Endocrine therapy Fulvestrant Letrozole Ribociclib

主题词人类(Humans);女(雌)性(Female);乳腺肿瘤(Breast Neoplasms);氨基吡啶类(Aminopyridines);中年人(Middle Aged);嘌呤类(Purines);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);绝经后期(Postmenopause);老年人(Aged);吗啉类(Morpholines);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);治疗结果(Treatment Outcome)

DOI 10.1016/j.clinsp.2023.100291

PMID 39491281

发布时间 2024-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinics (Sao Paulo, Brazil)

100291页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷